Announcements Trials
Browse Landscape

Phase

Phase NA 32Phase EARLY_PHASE1 6Phase 2 5Phase 3 4Phase 1 4Phase 4 2Phase 2/3 1Phase 1/2 1

Status

Completed 27Unknown 5Recruiting 5Terminated 4Active not recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 5

Sponsor

Conditions

Breast Neoplasms 311Carcinoma, Non-Small-Cell Lung 282Prostatic Neoplasms 160Colorectal Neoplasms 155Carcinoma, Hepatocellular 144Neoplasms 134Leukemia, Myeloid, Acute 132Lung Neoplasms 115Squamous Cell Carcinoma of Head and Neck 108Triple Negative Breast Neoplasms 102Multiple Myeloma 102Recurrence 99Pancreatic Neoplasms 94Stomach Neoplasms 93Ovarian Neoplasms 87Neoplasm Metastasis 87Lymphoma, Large B-Cell, Diffuse 81Sarcoma 70Precursor Cell Lymphoblastic Leukemia-Lymphoma 68Esophageal Neoplasms 67Uterine Cervical Neoplasms 66Melanoma 65Brain Neoplasms 65Rectal Neoplasms 62Head and Neck Neoplasms 62Glioblastoma 60Carcinoma, Renal Cell 57Lymphoma 55Myelodysplastic Syndromes 54Esophageal Squamous Cell Carcinoma 54

Interventions

Metformin 2maltodextrin 1artenimol 1Thioctic Acid 1Tablets 1Quercetin 1Contraceptives, Oral 1Capsules 1Acupuncture Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × Recruiting × Polycystic Ovary Syndrome × Clear all
NCT06852365 2026-06-01

COR-PCOS

University of Pennsylvania

Phase 2 Recruiting
100 enrolled

Polycystic Ovary Syndrome, Metabolic Syndrome

NCT07616037 2026-05-29

Efficacy of a GLP-1/FGF21 Dual Agonist for Treating PCOS

Shanghai Zhongshan Hospital

Phase 2 Recruiting
30 enrolled

Polycystic Ovary Syndrome

NCT07182526 2025-09-19

Effects of Adding Quercetin or Alpha Lipoic Acid to Usual Care on Symptoms and Blood Markers in Iraqi Women With Polycystic Ovary Syndrome

Al-Mustansiriyah University

Phase 2 Recruiting
150 enrolled

Polycystic Ovary Syndrome

NCT06842524 2025-04-20

Dihydroartemisinin for the Treatment of Polycystic Ovary Syndrome

Shanghai Zhongshan Hospital

Phase 2 Recruiting
150 enrolled

Polycystic Ovary Syndrome

NCT02647827 2024-10-09

PIAII

Karolinska Institutet

Phase 2 Recruiting
303 enrolled

Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡